MAM
DGX icon

Meeder Asset Management’s Quest Diagnostics DGX Stock Holding History

Meeder Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.7K Buy
182
+41
+29% +$7.97K ﹤0.01% 492
2025
Q4 		$24.5K Buy
141
+108
+327% +$19.7K ﹤0.01% 502
2025
Q3 		$6.29K Buy
33
+2
+6% +$355 ﹤0.01% 629
2025
Q2 		$5.57K Buy
31
+4
+15% +$695 ﹤0.01% 701
2025
Q1 		$4.57K Sell
27
-1,594
-98% -$262K ﹤0.01% 779
2024
Q4 		$245K Hold
1,621
– – 0.02% 207
2024
Q3 		$252K Sell
1,621
-55
-3% -$8.21K 0.02% 204
2024
Q2 		$229K Sell
1,676
-1,223
-42% -$167K 0.02% 199
2024
Q1 		$386K Sell
2,899
-3,294
-53% -$427K 0.02% 228
2023
Q4 		$854K Sell
6,193
-2,054
-25% -$270K 0.07% 148
2023
Q3 		$1M Buy
8,247
+564
+7% +$75.1K 0.08% 147
2023
Q2 		$1.08M Sell
7,683
-4,664
-38% -$643K 0.08% 155
2023
Q1 		$1.75M Buy
12,347
+7,021
+132% +$1M 0.14% 129
2022
Q4 		$833K Buy
5,326
+1,886
+55% +$271K 0.07% 206
2022
Q3 		$421K Buy
3,440
+1,428
+71% +$188K 0.02% 414
2022
Q2 		$267K Sell
2,012
-1,814
-47% -$247K 0.02% 541
2022
Q1 		$524K Buy
+3,826
New +$533K 0.03% 392
2021
Q4 		– Sell
-4,728
Closed -$688K – 1467
2021
Q3 		$688K Buy
4,728
+2,888
+157% +$423K 0.04% 340
2021
Q2 		$243K Sell
1,840
-4,113
-69% -$539K 0.01% 688
2021
Q1 		$765K Buy
5,953
+5,352
+891% +$659K 0.04% 325
2020
Q4 		$72K Buy
601
+39
+7% +$4.75K 0.02% 496
2020
Q3 		$64K Sell
562
-5,691
-91% -$672K ﹤0.01% 905
2020
Q2 		$712K Buy
6,253
+2,770
+80% +$294K 0.05% 302
2020
Q1 		$280K Buy
3,483
+2,120
+156% +$219K 0.02% 484
2019
Q4 		$145K Buy
1,363
+139
+11% +$14.5K 0.01% 692
2019
Q3 		$131K Buy
1,224
+512
+72% +$52.6K 0.01% 730
2019
Q2 		$72K Buy
+712
New +$68.4K 0.01% 841
2018
Q1 		– Sell
-458
Closed -$45K – 1604
2017
Q4 		$45K Sell
458
-3,316
-88% -$314K ﹤0.01% 715
2017
Q3 		$354K Sell
3,774
-31,043
-89% -$3.3M 0.04% 406
2017
Q2 		$3.87M Buy
34,817
+12,478
+56% +$1.32M 0.37% 75
2017
Q1 		$2.19M Sell
22,339
-5,390
-19% -$514K 0.2% 117
2016
Q4 		$2.55M Sell
27,729
-310
-1% -$26.7K 0.24% 100
2016
Q3 		$2.37M Buy
28,039
+16,571
+144% +$1.39M 0.2% 99
2016
Q2 		$934K Buy
11,468
+5,296
+86% +$403K 0.09% 249
2016
Q1 		$442K Buy
+6,172
New +$414K 0.04% 432
2015
Q3 		– Sell
-24,785
Closed -$1.8M – 698
2015
Q2 		$1.8M Sell
24,785
-15
-0.1% -$1.11K 0.18% 165
2015
Q1 		$1.91M Buy
24,800
+14,100
+132% +$1.01M 0.2% 146
2014
Q4 		$718K Buy
10,700
+676
+7% +$42.7K 0.09% 233
2014
Q3 		$609K Sell
10,024
-72
-0.7% -$4.44K 0.09% 192
2014
Q2 		$593K Buy
10,096
+910
+10% +$53.3K 0.09% 178
2014
Q1 		$532K Buy
+9,186
New +$492K 0.09% 167

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Meeder Asset Management's DGX Position: Q1 2026 in Review

Meeder Asset Management increased its Quest Diagnostics (DGX) stake by 29% in Q1 2026, buying an estimated $7.97K and bringing the position to 182 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Meeder Asset Management first reported a position in DGX in Q1 2014 and has held it in 41 quarters since. The position peaked at $3.87M in Q2 2017. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Meeder Asset Management held 182 shares of Quest Diagnostics worth $35.7K as of Q1 2026.
  • Meeder Asset Management bought 41 Quest Diagnostics shares in Q1 2026, an estimated $7.97K.
  • Quest Diagnostics made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #492 holding.
  • Meeder Asset Management first reported a position in Quest Diagnostics in Q1 2014 and has held it in 41 quarters since.
  • Meeder Asset Management's Quest Diagnostics position peaked at $3.87M in Q2 2017.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.